These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. Bartalena L; Marcocci C; Bogazzi F; Panicucci M; Lepri A; Pinchera A N Engl J Med; 1989 Nov; 321(20):1349-52. PubMed ID: 2811943 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Graves' disease. Utiger R N Engl J Med; 1978 Mar; 298(12):681-2. PubMed ID: 580106 [No Abstract] [Full Text] [Related]
17. The vanishing surgical treatment of Graves' disease: review of current literature and experience with 50 patients. Argov S; Duek D Curr Surg; 1982; 39(3):158-62. PubMed ID: 7047083 [No Abstract] [Full Text] [Related]
18. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment]. Kamoun M; Abid H; Lamine F; Slimane H; Haddad A Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063 [TBL] [Abstract][Full Text] [Related]
19. [Retrospective study of Graves ophthalmopathy in relation to thyroid treatment (author's transl)]. Franco Casique JJ; Bolanños Gil F; Llamas Esperón G; Maisterrena JA Rev Invest Clin; 1981; 33(4):361-4. PubMed ID: 6800010 [No Abstract] [Full Text] [Related]
20. The low occurrence of clinically significant ophthalmopathy after ablative treatment with radioactive iodine for Graves' hyperthyroidism. Ureles AL; Cronmiller JR J Nucl Med; 1993 Oct; 34(10):1829. PubMed ID: 8410313 [No Abstract] [Full Text] [Related] [Next] [New Search]